Jefferson University Hospitals

Physician Profile

David Rittenhouse, MD

Jefferson University Physician

Academic Title: Assistant Professor

Specialties
Surgery
Surgery - Trauma (Acute Care)

Make An Appointment

Click to call 1-800-JEFF-NOW (800-533-3669) or

Office Locations

Philadelphia
1100 Walnut Street
5th Floor
Philadelphia PA 19107
Phone: (215) 955-2165

Medical Services

Board Certifications

  • Surgery

Hospital Affiliation / Admitting Privileges

  • Thomas Jefferson University Hospital

Education

  • Jefferson Medical College, Medical School

Internship

  • Thomas Jefferson University Hospital

Residency

  • Thomas Jefferson University Hospital

Fellowship

  • Thomas Jefferson University Hospital

Recent Publications

Critical care in older adults

Gastroduodenal intussusception of a gastrointestinal stromal tumor (GIST): Case report and review of the literature

Infant with bilateral cataracts from non-Accidental trauma

Pancreatic cancer and premalignant tumors: Molecular aspects

HuR's post-transcriptional regulation of death receptor 5 in pancreatic cancer cells

Massive Portal Venous Air and Pneumatosis Intestinalis Associated with Cocaine-Induced Mesenteric Ischemia

Caveolin-1 and pancreatic ductal adenocarcinoma

Autoenucleation resulting in carotid thrombosis, subdural hemorrhage, stroke, and death

Subject Review: Pancreatic Ductal Adenocarcinoma in the Setting of Mutations in the Cystic Fibrosis Transmembrane Conductance Regulator Gene: Case Report and Review of the Literature

The Novel Triad of Dorsal Agenesis of the Pancreas with Concurrent Pancreatic Ductal Adenocarcinoma and Nonalcoholic Chronic Calcific Pancreatitis: A Case Series and Review of the Literature

Infantile choriocarcinoma in a neonate with massive liver involvement cured with chemotherapy and liver transplant

pp32 (ANP32A) expression inhibits pancreatic cancer cell growth and induces gemcitabine resistance by disrupting HuR binding to mRNAs

HuR status is a powerful marker for prognosis and response to gemcitabine-based chemotherapy for resected pancreatic ductal adenocarcinoma patients

A retrospective study of the factors associated with hypercoagulability in the pediatric patients at a tertiary care children's hospital